Vijaya Diagnostic Centre Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
828.00 +18.95 (2.34%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
812
Today’s High
833.3
52 Week Low
385.05
52 Week High
879.3
821.90 +12.20 (1.51%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
811.2
Today’s High
833
52 Week Low
387.55
52 Week High
880
Key Metrics
- Market Cap (In Cr) 8425.8
- Beta -
- Div. Yield (%) 0.12
- P/B 12.8
- TTM P/E 54.74
- Peg Ratio 2.53
- Sector P/E 27.33
- D/E 0.39
- Open Price 821
- Prev Close 809.05
Vijaya Diagnostic Centre Analysis
Price Analysis
-
1 Week-3.37%
-
3 Months34.74%
-
6 Month33.16%
-
YTD21.64%
-
1 Year110.42%
Risk Meter
- 36% Low risk
- 36% Moderate risk
- 36% Balanced Risk
- 36% High risk
- 36% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 3
- 3
- 3
- 1
- Hold
- 3
- 3
- 3
- 2
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 7
- 7
- 7
- 4
Vijaya Diagnostic Centre News
Vijaya Diagnostic Centre Q3 FY24 Results Live: profit rise by 57.96% YoY
1 min read . 07 Feb 2024Q3 results today: Bharti Airtel, Ashok Leyland, 120 others to release Q3 results
1 min read . 05 Feb 2024Day trading guide for stock market today: Six stocks to buy or sell on Monday
6 min read . 30 Oct 2023Vijaya Diagnostic Centre Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 547.81
- Selling/ General/ Admin Expenses Total
- 90.22
- Depreciation/ Amortization
- 57
- Other Operating Expenses Total
- 171.25
- Total Operating Expense
- 385.95
- Operating Income
- 161.85
- Net Income Before Taxes
- 158.68
- Net Income
- 118.83
- Diluted Normalized EPS
- 11.74
- Period
- 2024
- Total Assets
- 982.75
- Total Liabilities
- 325.56
- Total Equity
- 657.19
- Tangible Book Valueper Share Common Eq
- 50.5
- Period
- 2024
- Cashfrom Operating Activities
- 184.93
- Cashfrom Investing Activities
- -142.31
- Cashfrom Financing Activities
- -44.55
- Net Changein Cash
- -1.93
- Period
- 2023
- Total Revenue
- 459.04
- Selling/ General/ Admin Expenses Total
- 214.89
- Depreciation/ Amortization
- 61.72
- Other Operating Expenses Total
- 2.52
- Total Operating Expense
- 338.02
- Operating Income
- 121.03
- Net Income Before Taxes
- 113.51
- Net Income
- 84.63
- Diluted Normalized EPS
- 8.24
- Period
- 2023
- Total Assets
- 853.41
- Total Liabilities
- 308.68
- Total Equity
- 544.73
- Tangible Book Valueper Share Common Eq
- 52.57
- Period
- 2023
- Cashfrom Operating Activities
- 164.61
- Cashfrom Investing Activities
- -109.57
- Cashfrom Financing Activities
- -41.91
- Net Changein Cash
- 13.13
- Period
- 2022
- Total Revenue
- 462.15
- Selling/ General/ Admin Expenses Total
- 185.16
- Depreciation/ Amortization
- 52.69
- Other Operating Expenses Total
- 2.01
- Total Operating Expense
- 311.36
- Operating Income
- 150.79
- Net Income Before Taxes
- 147.38
- Net Income
- 109.68
- Diluted Normalized EPS
- 10.65
- Period
- 2022
- Total Assets
- 713.46
- Total Liabilities
- 245.24
- Total Equity
- 468.22
- Tangible Book Valueper Share Common Eq
- 45.26
- Period
- 2022
- Cashfrom Operating Activities
- 158
- Cashfrom Investing Activities
- -123.06
- Cashfrom Financing Activities
- -30.57
- Net Changein Cash
- 4.36
- Period
- 2021
- Total Revenue
- 376.49
- Selling/ General/ Admin Expenses Total
- 152.03
- Depreciation/ Amortization
- 50.45
- Other Operating Expenses Total
- 1.65
- Total Operating Expense
- 261.22
- Operating Income
- 115.27
- Net Income Before Taxes
- 112.12
- Net Income
- 84.48
- Diluted Normalized EPS
- 8.25
- Period
- 2021
- Total Assets
- 541.24
- Total Liabilities
- 182.23
- Total Equity
- 359.01
- Tangible Book Valueper Share Common Eq
- 34.5
- Period
- 2021
- Cashfrom Operating Activities
- 129.64
- Cashfrom Investing Activities
- -129.76
- Cashfrom Financing Activities
- -48.77
- Net Changein Cash
- -48.88
- Period
- 2020
- Total Revenue
- 338.71
- Selling/ General/ Admin Expenses Total
- 160.82
- Depreciation/ Amortization
- 49.17
- Other Operating Expenses Total
- 1.47
- Total Operating Expense
- 255.37
- Operating Income
- 83.34
- Net Income Before Taxes
- 83.43
- Net Income
- 62.54
- Diluted Normalized EPS
- 6.02
- Period
- 2020
- Total Assets
- 482.26
- Total Liabilities
- 207.71
- Total Equity
- 274.54
- Tangible Book Valueper Share Common Eq
- 26.26
- Period
- 2020
- Cashfrom Operating Activities
- 106.11
- Cashfrom Investing Activities
- -30.62
- Cashfrom Financing Activities
- -29.54
- Net Changein Cash
- 45.95
- Period
- 2019
- Total Revenue
- 292.52
- Selling/ General/ Admin Expenses Total
- 142.43
- Depreciation/ Amortization
- 39.63
- Other Operating Expenses Total
- 1.56
- Total Operating Expense
- 224.09
- Operating Income
- 68.43
- Net Income Before Taxes
- 65.32
- Net Income
- 45.87
- Diluted Normalized EPS
- 4.47
- Period
- 2019
- Total Assets
- 406.43
- Total Liabilities
- 199.05
- Total Equity
- 207.38
- Tangible Book Valueper Share Common Eq
- 19.59
- Period
- 2019
- Cashfrom Operating Activities
- 90.53
- Cashfrom Investing Activities
- -89.85
- Cashfrom Financing Activities
- -7.18
- Net Changein Cash
- -6.5
- Period
- 2024-03-31
- Total Revenue
- 155.21
- Selling/ General/ Admin Expenses Total
- 24.52
- Depreciation/ Amortization
- 16.3
- Other Operating Expenses Total
- 48.76
- Total Operating Expense
- 108.39
- Operating Income
- 46.81
- Net Income Before Taxes
- 43.87
- Net Income
- 33.45
- Diluted Normalized EPS
- 3.26
- Period
- 2024-03-31
- Total Assets
- 982.75
- Total Liabilities
- 325.56
- Total Equity
- 657.19
- Tangible Book Valueper Share Common Eq
- 50.5
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 184.93
- Cashfrom Investing Activities
- -142.31
- Cashfrom Financing Activities
- -44.55
- Net Changein Cash
- -1.93
- Period
- 2023-12-31
- Total Revenue
- 132.69
- Selling/ General/ Admin Expenses Total
- 23.03
- Depreciation/ Amortization
- 14.54
- Other Operating Expenses Total
- 41.37
- Total Operating Expense
- 96.98
- Operating Income
- 35.71
- Net Income Before Taxes
- 34.76
- Net Income
- 25.85
- Diluted Normalized EPS
- 2.67
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 138.86
- Selling/ General/ Admin Expenses Total
- 21.82
- Depreciation/ Amortization
- 13.69
- Other Operating Expenses Total
- 43.33
- Total Operating Expense
- 95.18
- Operating Income
- 43.68
- Net Income Before Taxes
- 44.58
- Net Income
- 33.32
- Diluted Normalized EPS
- 3.25
- Period
- 2023-09-30
- Total Assets
- 926.06
- Total Liabilities
- 329.31
- Total Equity
- 596.74
- Tangible Book Valueper Share Common Eq
- 57.4
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 94.67
- Cashfrom Investing Activities
- -80.01
- Cashfrom Financing Activities
- -15.61
- Net Changein Cash
- -0.96
- Period
- 2023-06-30
- Total Revenue
- 121.05
- Selling/ General/ Admin Expenses Total
- 20.85
- Depreciation/ Amortization
- 12.47
- Other Operating Expenses Total
- 37.79
- Total Operating Expense
- 85.4
- Operating Income
- 35.65
- Net Income Before Taxes
- 35.47
- Net Income
- 26.2
- Diluted Normalized EPS
- 2.56
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 120.99
- Selling/ General/ Admin Expenses Total
- 19.53
- Depreciation/ Amortization
- 11.36
- Other Operating Expenses Total
- 36.83
- Total Operating Expense
- 83.24
- Operating Income
- 37.75
- Net Income Before Taxes
- 36.5
- Net Income
- 27.49
- Diluted Normalized EPS
- 2.68
- Period
- 2023-03-31
- Total Assets
- 853.41
- Total Liabilities
- 308.68
- Total Equity
- 544.73
- Tangible Book Valueper Share Common Eq
- 52.57
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 164.61
- Cashfrom Investing Activities
- -109.57
- Cashfrom Financing Activities
- -41.91
- Net Changein Cash
- 13.13
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Vijaya Diagnostic Centre Technical
Moving Average
SMA
- 5 Day817.51
- 10 Day807.74
- 20 Day793.62
- 50 Day713.49
- 100 Day679.82
- 300 Day621.72
Vijaya Diagnostic Centre Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rainbow Childrens Medicare
- 1327.1
- 30.05
- 2.32
- 1649
- 880.05
- 13470.33
- Metropolis Healthcare
- 1955
- -42.6
- -2.13
- 2067.7
- 1260.05
- 10015.23
- Vijaya Diagnostic Centre
- 828
- 18.95
- 2.34
- 879.3
- 385.05
- 8474.22
- Healthcare Global Enterprises
- 379.05
- 9.45
- 2.56
- 401
- 286
- 5279.78
- Kovai Medical Centre and Hospital
- 4350
- 66.35
- 1.55
- 4777
- 2159.66
- 4759.88
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rainbow Childrens Medicare
- 60.81
- 10.48
- 19.88
- 13.8
- Metropolis Healthcare
- 80.71
- 9.38
- 20.59
- 14.66
- Vijaya Diagnostic Centre
- 69.21
- 12.65
- 22.14
- 21.2
- Healthcare Global Enterprises
- 114.83
- 6.32
- -4.88
- -3.5
- Kovai Medical Centre and Hospital
- 26.25
- 5.31
- 19.28
- 12.23
Vijaya Diagnostic Centre Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 08-May-24
- Audited Results & Final Dividend
- 05-Feb-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 29-May-23
- Audited Results & Dividend
- 13-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- 09-Aug-22
- Quarterly Results
- 26-May-22
- Audited Results & Final Dividend
- 04-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 20-Sept-23
- 29-May-23
- AGM
- 28-Sept-22
- 26-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 08-May-24
- -
- -
- 1
- 29-May-23
- 13-Sept-23
- 13-Sept-23
- 1
- 26-May-22
- 21-Sept-22
- 20-Sept-22
- 1